Latest News | Biocon Inks Licensing, Supply Pact with South Korea's Handok for Chronic Weight Management Product
Get latest articles and stories on Latest News at LatestLY. Biocon Ltd on Friday said it has signed an exclusive licensing and supply agreement with South Korea's Handok for commercialisation of its complex drug product, synthetic Liraglutide, used in the treatment of chronic weight management. Latest News | Biocon Inks Licensing, Supply Pact with South Korea's Handok for Chronic Weight Management Product.
Source: latestly.com